(Total Views: 458)
Posted On: 05/30/2019 8:29:24 PM
Post# of 154977
Your question on iHub the other day.
I found this from the latest poster.
Quote:
I wonder what percentage of CCR5 leronlimab blocks. We know from HIV that leronlimab can be overwhelmed by a mass proliferation of CCR5 targets. It's possible that an overexpression of miR-455-5p to reduce the number of CCR5 targets combined with leronlimab may produce an even better outcome than leronlimab alone.
I found this from the latest poster.
(0)
(0)
